These trials have been tested with 20+ different specialties piloted from Primary Health Care and Allied Health, and 200+ registered doctors and counting.
“We have conducted extensive market analysis – both on the customer and provider side. We understand that the healthcare industry is constantly under cost pressures, so it is critical to build solutions at the highest quality and capability possible but be justifiably affordable. Our view is that we have achieved this outcome, with MedTalk.co positioned at least 50 per cent cheaper than major alternative providers,” said Nisar.
Read more on The Daily Advertiser
This news is powered by The Daily Advertiser 
